Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant RCAS1 anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement RCAS1 dans IHC. Il présente une réactivité avec des échantillons de Humain.
N° du produit ABIN7863774
639,45 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour Recombinant RCAS1 anticorps (ABIN7863774)

Antigène

Voir toutes RCAS1 (EBAG9) Anticorps
RCAS1 (EBAG9) (Estrogen Receptor Binding Site Associated, Antigen, 9 (EBAG9))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 67
  • 31
  • 13
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 45
  • 35
  • 2
Souris

Clonalité

  • 43
  • 39
Monoclonal

Conjugué

  • 40
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp RCAS1 est non-conjugé

Application

  • 35
  • 33
  • 20
  • 16
  • 15
  • 13
  • 13
  • 12
  • 5
  • 3
  • 2
  • 2
  • 1
Immunohistochemistry (IHC)

Clone

REBAG9-7264
  • Fonction

    Recombinant RCAS1 / Estrogen Receptor Binding Site Associated, Antigen 9 Antibody

    Specificité

    EBAG9, also known as RCAS1, is an estrogen-transcribed protein. Soluble and membranous RCAS1 proteins may play a role in the immune escape of tumor cells by promoting T lymphocyte inhibition of growth and apoptosis. RCAS1 is expressed in a wide variety of cancers, including uterine, ovarian, and lung cancer cells, and acts as a ligand for a putative receptor present on peripheral lymphocytes. RCAS1 is highly expressed not only in cancer cells but also in non-tumor bile duct cells subject to immune attack. RCAS1 inhibits the in vitro growth of receptor-expressing cells and induces apoptosis, contributing to the ability of tumor cells to evade host immune surveillance. High expression of RCAS1 significantly correlates with tumor progression and with poor outcome for many cancer patients.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant full-length human EBAG9 protein

    Isotype

    IgG1, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    RCAS1 (EBAG9) (Estrogen Receptor Binding Site Associated, Antigen, 9 (EBAG9))

    Autre désignation

    RCAS1

    Sujet

    BAG9, cancer associated surface antigen, cancer associated surface antigen RCAS1, EB9, estrogen receptor binding fragment associated gene 9, PDAF, receptor binding cancer antigen expressed on SiSo cells

    Jurkat or HEK-293 cell lysates. Human skeletal muscle tissue.|MCF-7

    Poids moléculaire

    32kDa

    ID gène

    9166, 409368

    UniProt

    O00559
Vous êtes ici:
Chat with us!